Meeder Advisory Services Inc. Acquires Shares of 5,936 HCA Healthcare, Inc. $HCA

Key Points

• Meeder Advisory Services acquired 5,936 shares of HCA Healthcare in the second quarter, valued at approximately $2.31 million. Institutional investors collectively own 62.73% of the company.
• HCA reported quarterly earnings of $7.59 per share, slightly exceeding estimates, while revenue rose 8.7% year over year to $20.23 billion. The company also declared a quarterly dividend of $0.78 per share, representing a 0.8% annualized yield.
• Analysts maintain a consensus “Moderate Buy” rating, with an average price target of $465.59, compared with shares recently trading at $412.27.

Meeder Advisory Services Inc. bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 5,936 shares of the company's stock, valued at approximately $2,314,000.

A number of other large investors have also recently made changes to their positions in the business. Palisade Asset Management LLC purchased a new position in shares of HCA Healthcare during the third quarter valued at approximately $26,000. MidFirst Bank purchased a new position in HCA Healthcare during the 2nd quarter valued at $28,000. Clearstead Trust LLC purchased a new stake in shares of HCA Healthcare in the 2nd quarter worth about $29,000. Ares Financial Consulting LLC purchased a new position in shares of HCA Healthcare during the fourth quarter valued at about $31,000. Finally, Cedar Mountain Advisors LLC purchased a new stake in HCA Healthcare in the first quarter worth about $33,000. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $412.27 on Wednesday. The company has a market capitalization of $89.26 billion, a PE ratio of 13.80, a PEG ratio of 1.40 and a beta of 1.10. The business has a fifty day moving average price of $395.07 and a 200-day moving average price of $445.35. HCA Healthcare, Inc. has a 1-year low of $353.99 and a 1-year high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. The company had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. HCA Healthcare's revenue for the quarter was up 8.7% on a year-over-year basis. During the same period in the prior year, the firm posted $6.84 EPS. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 29.47 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be given a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare's dividend payout ratio is 10.45%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on HCA shares. UBS Group decreased their target price on HCA Healthcare from $635.00 to $579.00 and set a "buy" rating for the company in a research report on Monday, July 27th. Robert W. Baird reduced their price target on HCA Healthcare from $396.00 to $393.00 and set a "neutral" rating on the stock in a research note on Monday, July 27th. Stephens dropped their target price on shares of HCA Healthcare from $560.00 to $530.00 and set an "overweight" rating on the stock in a report on Monday, April 27th. TD Cowen decreased their price target on shares of HCA Healthcare from $500.00 to $431.00 and set a "buy" rating for the company in a research note on Monday, June 22nd. Finally, Wall Street Zen cut shares of HCA Healthcare from a "buy" rating to a "hold" rating in a report on Saturday, May 2nd. Fourteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $465.59.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source